323 related articles for article (PubMed ID: 22356480)
1. Serologic and molecular characterization of D variants in Brazilians: impact for typing and transfusion strategy.
Credidio DC; Pellegrino J; Castilho L
Immunohematology; 2011; 27(1):6-11. PubMed ID: 22356480
[TBL] [Abstract][Full Text] [Related]
2. Variant RHD Types in Brazilians With Discrepancies in RhD Typing.
Campos FC; Mota MA; Aravechia MG; Torres KB; Bub CB; Kutner JM; Castilho L
J Clin Lab Anal; 2016 Nov; 30(6):845-848. PubMed ID: 27076392
[TBL] [Abstract][Full Text] [Related]
3. Combining serology and molecular typing of weak D role in improving D typing strategy in Egypt.
Abdelrazik AM; Elshafie SM; Ezzat Ahmed GM; Abdelaziz HM
Transfusion; 2013 Nov; 53(11 Suppl 2):2940-4. PubMed ID: 23362929
[TBL] [Abstract][Full Text] [Related]
4. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention.
Denomme GA; Wagner FF; Fernandes BJ; Li W; Flegel WA
Transfusion; 2005 Oct; 45(10):1554-60. PubMed ID: 16181204
[TBL] [Abstract][Full Text] [Related]
5. Novel weak D types 31 and 32: adsorption-elution-supported D antigen analysis and comparison to prevalent weak D types.
Körmöczi GF; Förstemann E; Gabriel C; Mayr WR; Schönitzer D; Gassner C
Transfusion; 2005 Oct; 45(10):1574-80. PubMed ID: 16181207
[TBL] [Abstract][Full Text] [Related]
6. RHD variants in Flanders, Belgium.
Van Sandt VS; Gassner C; Emonds MP; Legler TJ; Mahieu S; Körmöczi GF
Transfusion; 2015 Jun; 55(6 Pt 2):1411-7. PubMed ID: 25413499
[TBL] [Abstract][Full Text] [Related]
7. Identification of RHD alleles with the potential of anti-D immunization among seemingly D- blood donors in Upper Austria.
Polin H; Danzer M; Gaszner W; Broda D; St-Louis M; Pröll J; Hofer K; Gabriel C
Transfusion; 2009 Apr; 49(4):676-81. PubMed ID: 19170995
[TBL] [Abstract][Full Text] [Related]
8. RHD alleles among pregnant women with serologic discrepant weak D phenotypes from a multiethnic population and risk of alloimmunization.
Bub CB; Aravechia MG; Costa TH; Kutner JM; Castilho L
J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28374955
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive analysis of DEL types: partial DEL individuals are prone to anti-D alloimmunization.
Körmöczi GF; Gassner C; Shao CP; Uchikawa M; Legler TJ
Transfusion; 2005 Oct; 45(10):1561-7. PubMed ID: 16181205
[TBL] [Abstract][Full Text] [Related]
10. Serologic profiling of D variants in donor routine: unveiling the impact on false-negative results and alloimmunization.
Arnoni CP; Vendrame TA; Silva FS; Silva NM; Cortez A; Latini F; Castilho L
Immunohematology; 2024 Jun; 40(2):47-53. PubMed ID: 38910444
[TBL] [Abstract][Full Text] [Related]
11. Primary anti-D immunization by DEL red blood cells.
Kim KH; Kim KE; Woo KS; Han JY; Kim JM; Park KU
Korean J Lab Med; 2009 Aug; 29(4):361-5. PubMed ID: 19726900
[TBL] [Abstract][Full Text] [Related]
12. Molecular RH blood group typing of serologically D-/CE+ donors: the use of a polymerase chain reaction-sequence-specific primer test kit with pooled samples.
Londero D; Fiorino M; Miotti V; de Angelis V
Immunohematology; 2011; 27(1):25-8. PubMed ID: 22356483
[TBL] [Abstract][Full Text] [Related]
13. Correlation between serology and genetics of weak D types in Denmark.
Christiansen M; Samuelsen B; Christiansen L; Morbjerg T; Bredahl C; Grunnet N
Transfusion; 2008 Jan; 48(1):187-93. PubMed ID: 17900277
[TBL] [Abstract][Full Text] [Related]
14. Anti-D alloimmunisation in pregnant women with DEL phenotype in China.
Wang M; Wang BL; Xu W; Fan DD; Peng ML; Pan J; Yao P; Jiang GM; Wan XJ
Transfus Med; 2015 Jun; 25(3):163-9. PubMed ID: 26033335
[TBL] [Abstract][Full Text] [Related]
15. Is current serologic RhD typing of blood donors sufficient for avoiding immunization of recipients?
Krog GR; Clausen FB; Berkowicz A; Jørgensen L; Rieneck K; Nielsen LK; Dziegiel MH
Transfusion; 2011 Nov; 51(11):2278-85. PubMed ID: 21569040
[TBL] [Abstract][Full Text] [Related]
16. Weak D phenotypes and transfusion safety: where do we stand in daily practice?
Noizat-Pirenne F; Verdier M; Lejealle A; Mercadier A; Bonin P; Peltier-Pujol F; Fialaire-Legendre A; Tournamille C; Bierling P; Ansart-Pirenne H
Transfusion; 2007 Sep; 47(9):1616-20. PubMed ID: 17725725
[TBL] [Abstract][Full Text] [Related]
17. Secondary anti-D immunization by Del red blood cells.
Yasuda H; Ohto H; Sakuma S; Ishikawa Y
Transfusion; 2005 Oct; 45(10):1581-4. PubMed ID: 16181208
[TBL] [Abstract][Full Text] [Related]
18. Frequency and characterization of RHD variant alleles in a population of blood donors from southeastern Brazil: Comparison with other populations.
Rodrigues ES; Romagnoli AC; Santos FLS; Cutter TB; Catelli LF; Cédric V; Peyrard T; Covas DT; de Castilho LM; Kashima S
Transfus Apher Sci; 2021 Aug; 60(4):103135. PubMed ID: 33867285
[TBL] [Abstract][Full Text] [Related]
19. Rh discrepancies caused by variable reactivity of partial and weak D types with different serologic techniques.
Denomme GA; Dake LR; Vilensky D; Ramyar L; Judd WJ
Transfusion; 2008 Mar; 48(3):473-8. PubMed ID: 18067505
[TBL] [Abstract][Full Text] [Related]
20. Reactivity of FDA-approved anti-D reagents with partial D red blood cells.
Judd WJ; Moulds M; Schlanser G
Immunohematology; 2005; 21(4):146-8. PubMed ID: 16472014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
